Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy
The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune syste...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Book Chapter |
| Published: |
Frontiers Media SA
2017
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01778naaaa2200325uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_55224 | ||
| 005 | 20210211 | ||
| 020 | |a 978-2-88945-358-0 | ||
| 020 | |a 9782889453580 | ||
| 024 | 7 | |a 10.3389/978-2-88945-358-0 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Benjamin Gesundheit |4 auth | |
| 700 | 1 | |a Joshua P. Rosenzweig |4 auth | |
| 245 | 1 | 0 | |a Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy |
| 260 | |b Frontiers Media SA |c 2017 | ||
| 300 | |a 1 electronic resource (193 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The ability to genetically engineer oncolytic viruses in order to minimize side effects and improve the selective targeting of tumor cells has opened up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. Theranostic biomarkers to monitor these therapies in clinical trials serve an important need in this innovative field and demand further research. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 653 | |a theranostic nanomedicine | ||
| 653 | |a cancer immunotherapy | ||
| 653 | |a oncolytic viruses | ||
| 653 | |a antitumor immunity | ||
| 653 | |a oncoimmunology | ||
| 653 | |a gene expression | ||
| 653 | |a transgenes | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://www.frontiersin.org/research-topics/5352/oncolytic-viruses---genetically-engineering-the-future-of-cancer-therapy |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/55224 |7 0 |z DOAB: description of the publication |